Using Generic Drugs to Reduce the Cost of Care
Hours: 0.50
Generic drugs have been lifesaving for many Americans faced with dire financial situations and no comprehensive medical coverage. On average, a brand-name drug costs at least three or four times the price of a generic drug. For someone who takes multiple drugs every day, the costs can be prohibitive. Some prescribers do not prescribe generics out of habit or out of concern that the generic may not be safe or effective. In some cases, prescribers have no idea that generic counterparts exist and consequently never bother to write it on the prescription. APNs with prescriptive authority must be informed about the use of generic drugs. Patients may also be reluctant to use generic drugs, and RNs, pharmacists, and technicians play a critical role in educating them about generic drug usage.
Generic drugs have been lifesaving for many Americans faced with dire financial situations and no comprehensive medical coverage. On average, a brand-name drug costs at least three or four times the price of a generic drug. For someone who takes multiple drugs every day, the costs can be prohibitive. Some prescribers do not prescribe generics out of habit or out of concern that the generic may not be safe or effective. In some cases, prescribers have no idea that generic counterparts exist and consequently never bother to write it on the prescription. APNs with prescriptive authority must be informed about the use of generic drugs. Patients may also be reluctant to use generic drugs, and RNs, pharmacists, and technicians play a critical role in educating them about generic drug usage.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.50 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 0.50 Nursing Contact Hours after successfully completing this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 0.50 contact hours for participating in this course.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 0.50 contact hours for participating in this course.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-22-008-H01-P
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: [Custom_Code]
Target Audience Designation: [Custom_Code2]
ACPE Universal Activity Number: JA4008266-0000-22-008-H01-T
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 0.50 contact hours.
Recall the requirements and the process for approval of a generic drug in the U.S.
Identify potential barriers and patient education needs related to generic drugs.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Understanding Generic Medications
Overview
What Is a Generic Drug?
Generic Drugs in the U.S.
Approval Process
Cost Savings
Summary
Section 3: Considerations for Accessing Generic Medications
Legal Considerations
Biosimilar Biological Drugs
Patient Concerns
Summary
Section 4: Clinical Vignette
Visiting Louise
Section 5: Conclusion
Course Summary
Course Contributors
Resources
References
Robert graduated from The University of Texas College of Pharmacy in 2014 and has worked with both pediatric and adult populations in outpatient and inpatient settings. He currently works as a clinical support pharmacist at a federally qualified health care center in Houston Texas focusing on chronic disease state management and HIV and Hepatitis C care. Disclosure: Robert Smith, PharmD has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.Writer: Kimberly Workman, MA
Ms. Workman is an Instructional Designer at Relias. She has a Master of Arts in Technology and Communication, as well as graduate certificates in Public Health, Epidemiology, and Digital Communications. Ms. Workman has a background in writing and designing online continuing medical education for physicians and other health professionals on multiple educational platforms, including web-based, game-based, and immersive learning environments. She has also used simulation training extensively to connect learning to real-world environments. Disclosure: Kimberly Workman, MA discloses the following potential conflict of interests/commercial interests: Relevant Financial Relationship with Relias LLC as a Salaried Employee All of the relationships listed for this individual have been mitigated.Relevant Non-Financial Relationship with No Entities Exists as a Contributor All of the relationships listed for this individual have been mitigated.
The target audience for this course is: Nurses; Pharmacists; Pharmacy Technicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
